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Abstract
Purpose To assess the grading of Crohn’s disease activity
using CT, MRI, US and scintigraphy.
Materials and methods MEDLINE, EMBASE and Cochrane
databases were searched (January 1983–March 2014) for
studies evaluating CT, MRI, US and scintigraphy in grading
Crohn’s disease activity compared to endoscopy, biopsies or
intraoperative findings. Two independent reviewers assessed
the data. Three-by-three tables (none, mild, frank disease)
were constructed for all studies, and estimates of accurate,
over- and under-grading were calculated/summarized by fixed
or random effects models.
Results Our search yielded 9356 articles, 19 of which were
included. Per-patient data showed accurate grading values for
CT, MRI, US and scintigraphy of 86 % (95 % CI: 75–93 %),
84 % (95 % CI: 67–93 %), 44 % (95 % CI: 28–61 %) and
40 % (95 % CI: 16–70 %), respectively. In the per-patient
analysis, CT and MRI showed similar accurate grading esti-
mates (P=0.8). Per-segment data showed accurate grading
values for CT and scintigraphy of 87 % (95 % CI: 77–93 %)
and 86 % (95 % CI: 80–91 %), respectively. MRI and US
showed grading accuracies of 67–82 % and 56–75 %,
respectively.
Conclusions CT and MRI showed comparable high accurate
grading estimates in the per-patient analysis. Results for US
and scintigraphy were inconsistent, and limited data were
available.
Key Points
• CT and MRI have comparable high accuracy in grading
Crohn’s disease.
• Data on US and scintigraphy is inconsistent and limited.
• MRI is preferable over CT as it lacks ionizing radiation
exposure.
Keywords Crohn’s disease . X-ray computed tomography .
Magnetic resonance imaging . Ultrasound . Radionuclide
imaging
Introduction
Cross-sectional imaging techniques are widely used for diag-
nosis and evaluation of Crohn’s disease. Numerous studies
have evaluated the diagnostic accuracy of cross-sectional im-
aging techniques in patients with Crohn’s disease, and a meta-
analysis was published that investigated the diagnostic accu-
racy of computed tomography (CT), magnetic resonance im-
aging (MRI), ultrasound (US) and scintigraphy [1]. However,
clinical monitoring and choice of therapy largely rely on grad-
ing of disease activity.
Clinical symptoms and inflammatory lesions can exist in-
dependently, so assessment of the bowel is essential in guiding
therapy decisions [2]. If inflammation is present, it is impor-
tant to distinguish between mild, moderate and severe disease,
as medical management differs among these stages [3].
Ileocolonoscopy, the current reference standard for luminal
Crohn’s disease, is accurate for assessing mucosal abnormal-
ities, but it has several drawbacks, as it is an invasive tech-
nique, is associated with the risk of bowel perforation, is in-
capable of assessing trans- and extraluminal disease, and is
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limited to the colon and terminal ileum [4]. Video capsule
endoscopy (VCE) is a well-tolerated and accurate alternative
to ileocolonoscopy that allows assessment of the whole gas-
trointestinal tract, although it has shown lower specificity and
bears the risk of capsule retention, which occurs in up to 13 %
of patients with Crohn’s disease [5].
Cross-sectional imaging techniques that could accurately
grade disease severity would be preferable to ileocolonoscopy,
as they are non-invasive and not limited to the colon and
terminal ileum. Several studies have looked at the use of
cross-sectional imaging for assessing the severity of
Crohn’s disease, but offered no comparison between imaging
techniques, as no meta-analysis was performed [2, 6]. To our
knowledge, only one such meta-analysis has been performed,
but it evaluated only MRI and used a search period that ended
in April 2007 [7]. This study showed that MRI correctly grad-
ed disease activity in 91 % of patients with frank (moderate-
to-severe) disease. However, correct grading was limited in
patients with disease in remission and with mild disease
(62 % for both). Furthermore, no comparison with other im-
aging techniques was made and numerous articles on the grad-
ing of Crohn’s disease using MRI have been published since
2007.
Our purpose was to systematically review and compare the
accuracy of CT, MRI, US, scintigraphy and positron emission
tomography–computed tomography (PET-CT) in grading
Crohn’s disease activity on a per-patient or per-segment basis
as compared to endoscopy, biopsies or intraoperative findings
by performing a meta-analysis. Furthermore, we aimed to in-
vestigate the degree of over- and under-grading for these im-
aging techniques.
Material and methods
This review was conducted according to the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines [8]. The review protocol was not pub-
lished or registered in advance.
Literature search and strategy
We performed an electronic search in MEDLINE, EMBASE
and Cochrane databases for studies examining the accuracy of
CT, MRI, US, scintigraphy and PET (-CT) for grading
Crohn’s disease activity in human subjects. Search terms
‘Crohn’s disease’ and ‘inflammatory bowel disease’ were
combined using ‘OR’ and search terms for imaging modalities
were combined using ‘OR’ as well. These two groups were
combined using ‘AND’. The search period was limited from
January 1983 toMarch 2014. Details of the search strategy are
provided in the electronic supplementary material (Appendix
E1).
Study selection on title and abstract
All articles retrieved from the electronic search were assessed
by one observer (CP). Non-relevant articles and articles in the
form of a review, case report, comment or letter were exclud-
ed. Subsequently, the remaining titles and abstracts were in-
dependently assessed by two observers (CP, JT) to identify
potentially eligible articles. In cases of uncertainty, articles
were deemed potentially eligible and retrieved as full text.
Study selection on full text
The full texts of the remaining articles were retrieved. Two
observers (CP, JT) independently reviewed all eligible articles
for the following inclusion criteria: (a) ten or more patients
were included (fewer were considered case-series); (b) CT,
MRI, US, scintigraphy or PET (-CT) was used to grade
Crohn’s disease activity; (c) patients with clinically suspected
inflammatory bowel disease (IBD) or known IBD/Crohn’s
disease were included; (d) endoscopy, biopsies or intraopera-
tive findings were used as a reference test; (e) imaging features
used for grading disease activity were defined; (f) raw data
were available to construct 3×3 tables; (g) articles were writ-
ten in English, Italian, Spanish, French, German or Dutch; and
(h) patients with Crohn’s disease could be analysed separately
from other IBD patients. No patient age limits were applied.
Articles in the form of a review, case report, conference ab-
stract, comment or letter were excluded. In the case of dupli-
cate publications, we excluded the studies with the lower
number of patients. Disagreement regarding potential eligibil-
ity and inclusion was resolved by consensus. The observers
were not blinded to author and journal names.
Study characteristics
Methodological characteristics Both reviewers extracted
study characteristics independently for all included arti-
cles using a standardized form. To assess the quality of
the study design, we used a modified Quality Assess-
ment of Diagnostic Accuracy Studies 2 (QUADAS 2)
tool [9, 10], as it separately assesses risk of bias in
several methodological domains (patient selection, index
test, reference test and patient flow) using a number of
signalling questions (Table 1). Risk of bias for each
domain was described as high, low or unclear. In addi-
tion, concerns regarding the applicability of the patient
population, index and reference test to the review ques-
tion were rated by the observers as high, low or unclear.
Disagreements were resolved by discussion.
Patient characteristics The following patient characteris-
tics were recorded: number of patients included, number
of patients in the analysis, whether patients were
3296 Eur Radiol (2015) 25:3295–3313
recruited consecutively, age characteristics, gender ratio,
patient spectrum (i.e. known or suspected IBD or
Crohn’s disease) and other selection criteria for patient
inclusion.
Imaging characteristics Imaging characteristics concerning
type of equipment and basic specifications (type of scanner for
CT, field strength and coil type for MRI, and transducer type
for US), techniques used for evaluation (sequences for MRI,
use of Doppler for US, labelling target and tracer type for
scintigraphy), bowel preparation (fasting and/or laxatives),
use of luminal and/or intravenous contrast medium, timing
of post-contrast scans and use of spasmolytic drugs were
extracted.
Reference test All reference tests (i.e. endoscopy, biopsies or
intraoperative findings) used for analysis were recorded.
Imaging and reference test interpretation We recorded the
following information regarding interpretation of imaging and
reference tests: the interval in days between index and refer-
ence tests, bowel segments that were examined, grading
criteria used for imaging and reference tests, imaging features
used for evaluation of disease activity, and whether
grading was performed on a per-patient and/or per-
bowel-segment basis.
Table 1 Methodological characteristics from the QUADAS tool and their corresponding signalling questions [9, 10]. The risk of bias is determined for
every domain using the signalling questions
Modified QUADAS Methodological Characteristics
Domain Signalling questions
(Yes, no, unclear)
Patient selection Was a consecutive or random sample of patients enrolled?
Was a case–control design avoided?
Did the study avoid inappropriate exclusions?
Index test Were the index test results interpreted without knowledge of
the results of the reference test?
If a threshold was used, was it pre-specified?
Was the execution and interpretation (expertise, image analysis) of the index
test described in sufficient detail to permit its replication? a
Reference test Is the reference test likely to correctly classify the target condition?
Were the reference test results interpreted without knowledge of the results
of the index test?
Was the execution and interpretation of the reference test described in
sufficient detail to permit its replication? a
Patient flow Was there an appropriate interval between index test(s) and reference test
(>1 month)?
Did all patients receive a reference test?
Did all patients receive the same reference test?
Were all patients included in the analysis?
Prospective / Retrospective b Was the data collected after the research question was defined?
a This signalling question was added from QUADAS 1 [10]. We considered this question essential for quality assessment, while it is not part of
QUADAS 2 [9]
b This item was not part of the QUADAS tool
Fig. 1 Flow diagram showing study selection
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Data extraction
Grading results for imaging and reference tests were
extracted with the grading scales used in individual
studies (i.e. three-, four-, or five-grade scales). From
this data, three-by-three contingency tables comparing
results from index and reference tests categorized as
none, mild or frank disease were constructed for each
study. These categories did not use predefined
criteria, but were formed either by using the original
grading from each study (in the case of a three-grade
scale) or by merging certain grades to form a three-
grade scale. If a four-grade scale was used (none,
mild, moderate or severe disease), groups with mod-
erate and severe disease were merged into frank dis-
ease. For five-grade scales, the second and third
scales were grouped into mild disease and the fourth
and fifth were grouped into frank disease. When stud-
ies used multiple reference tests, we used intraopera-
tive findings as the reference standard. In other cases,
histological findings from biopsies were preferred
over endoscopic findings. Because the imaging results
in these studies were based on the most severe lesion,
we considered histological data from biopsies as more
lesion-specific and better resembling imaging results
than endoscopic results.
Publication bias
To study publication bias, we followed the method by
Deeks et al., as recommended in the Cochrane hand-
book for DTA reviews [11]. We first calculated effective
sample sizes (ESS) for each study. We then performed
linear regression analyses if enough datasets were avail-
able in a group (n>5), with the proportion of accurate
grading per study as the independent variable and
1/√ESS as the dependent variable. A significant regres-
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Sufficient detail to replicate
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* For index tests CT and scintigraphy, the answer here were no and yes, respectively. Any other
signaling questions regarding CT and scintigraphy for this study were answered identically. 
Fig. 2 QUADAS signalling
questions (Table 1) per domain
(from up to down: patient selec-
tion, index test, reference test and
patient flow). The last column
shows whether studies included
patients prospectively.
Patient selection
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Fig. 3 QUADAS risk of bias per
domain and concerns regarding
applicability for domains of
patient selection, index test and
reference test
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Data analysis
For each study, we constructed three proportions: ‘accurate
grading’, defined as the number of correctly graded patients
or segments; ‘under-grading’, defined as the number of pa-
tients or segments on which the index test graded lower than
the reference test; and ‘over-grading’, defined as the number
of patients or segments on which the index test graded disease
activity higher than the reference test. Datasets were sorted
into groups by type of imaging, which were then subdivided
by target of evaluation (per-patient or per-segment). To quan-
tify heterogeneity we calculated the I2-statistic for each group.
Data were pooled if more than one dataset was avail-
able in a group and the data were not too heterogeneous
(I2<75 %) [12].
For the pooled data, we calculated mean logit accurate
grading and under- and over-grading values with correspond-
ing standard errors using non-linear fixed or random effects
models based on the Akaike information criterion (AIC) sta-
tistic (a lower AIC value indicates a better fit) [13, 14]. Using
anti-logit transformation, we obtained summary estimates
with 95% confidence intervals (95 % CI) for accurate grading
and over- and under-grading. In several studies, multiple
datasets were available (i.e. multiple readers). Because we
used all datasets for analysis, we adjusted the correlation be-
tween datasets from the same study by adding the same num-
ber for each study in the subject statement of the random
effects approach.
Comparison of CT, MRI, US and scintigraphy was per-
formed with Z-tests using the logit values of the pooled data.
For data that was not pooled, we performed logit transforma-
tion using proportion and sample size (n) to enable compari-
son. To calculate logit values for proportions of 0 or 100, we
added 0.5 to the number of events [15]. P values less than 0.05
indicated a statistically significant difference. All data analy-
ses were performed using Excel 2010 (Microsoft Corporation,
Redmond, WA, USA), SPSS 22.0 (IBM SPSS Statistics for
Macintosh, Version 22.0; IBM Corp., Armonk, NY, USA),
and SAS 9.3 (SAS Institute, Cary, NC, USA) software
programs.
Results
Search and study selection
The search yielded 9356 articles. After selection on title and/
or abstract, 149 articles remained and were retrieved as full-
text articles (Fig. 1). Of these remaining articles, 130 did not
fulfil the eligibility criteria (Appendix E2). Nineteen articles
met all inclusion criteria and were included for further data
extraction. CTwas evaluated in 3 [16–18],MRI in 11 [19–29],
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articles evaluating PET-CT were found that met our
criteria.
Study characteristics
Methodological characteristics Evaluation of the imaging
tests was performed blinded from the reference test in 13
studies [17, 18, 21, 22, 24–30, 33, 34]. The reference test
was performed blinded to the imaging results in 12 studies
[16, 17, 19, 21, 24, 26–30, 33, 34]. The remaining studies
did not specify whether observers were blinded to other results
[20, 23, 31, 32]. Fifteen of the studies included patients pro-
spectively [16–26, 28, 30, 31, 34]. Signalling questions for the
QUADAS tool were answered with ‘yes’ in 78.9 % of cases
(Fig. 2). Patient selection and index test domains showed less
risk of bias than reference test and patient flow domains. Con-
cern about applicability of patient selection and index and
reference tests was generally low (Fig. 3).
Patient characteristics A total of 549 patients were included
(75 for CT, 347 for MRI, 86 for US, and 58 for scintigraphy).
The mean study size was 29 patients (range, 10–76). Study
characteristics are presented in Table 2. In ten of the studies,
patients were recruited consecutively [17, 19, 20, 22–26, 28,
31]. Studies included patients with clinically suspected IBD,
known IBD/Crohn’s disease, or a combination of both (12, 4,
and 3 studies, respectively).
Imaging characteristics Imaging equipment and specifica-
tions are presented in Tables 3, 4, 5 and 6. Bowel preparation
(fasting and/or laxatives) was used in eight studies (1 CT, 7
MRI) [17, 21–26, 28]. Luminal contrast medium was used in
ten studies (3 CT, 7 MRI) [16–18, 21–23, 25, 27–29], of
which one used enteroclysis [27]. Intravenous contrast medi-
um was used in 13 studies (2 CT, 11 MRI) [16, 17, 19–29].
Reference test Endoscopy, biopsies and intraoperative find-
ings were used in 11, 8 and 4 studies, respectively (Table 7).
Three studies recorded results for both endoscopy and
histology from biopsies, for which we used the histo-
logical data in our analysis [30, 33, 34].
Imaging and reference test interpretation Thirteen of the
studies used an interval of less than one month between
imaging and reference test [17, 19–23, 26, 28, 29,
31–34]. The imaging features most commonly used for
evaluation were bowel wall thickness and post-contrast
enhancement (or tracer uptake for scintigraphy), which
were both used in 17 studies (Table 7). The reference
test and imaging criteria for each study are presented in
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Publication bias
Linear regression analysis on MRI per-patient data showed a
regression coefficient of 0.4 (95 % CI: −0.9 to 0.9), with no
significant relationship between accurate grading and 1/√ESS
(P=0.09). Data in other groups were deemed insufficient for
performing linear regression analyses.
Data analysis
Results from our data analysis are presented in Table 10.
Three-by-three contingency tables for each study can be found
in the supplementary materials (Appendix E3).
Per-patient Data was provided on a per-patient basis in 13
studies (evaluating CT in 2, MRI in 9, US in 1 and scintigra-
phy in 1) (Fig. 4). I2 values for overall grading accuracy for
groups with more than one dataset were as follows: 67.7 %
(95 % CI: 42.6–81.8 %) for CT, and 73.9 % (95 % CI: 56.2−
84.4 %) for MRI.
CT and MRI data were pooled for each modality (I2<
75 %). US and scintigraphy were not pooled, as only one
dataset was available for each modality. CT, MRI, US and
scintigraphy showed accurate grading estimates of 86 %
(95 % CI: 75–93 %), 84 % (95 % CI: 67–93 %), 44 %
(95 % CI: 28–61 %) and 40 % (95 % CI: 16–70 %), respec-
tively. CT and MRI showed similar overall grading accuracy
(P=0.8), both higher than US (P=0.0001 and P=0.001, re-
spectively) and scintigraphy (P=0.003 and P=0.01, respec-
tively). CT and MRI showed similar over-grading (P=0.8)
and under-grading (P=0.5). Both showed less under-grading
than US (P=0.002 and P=0.003, respectively) and scintigra-
phy (P=0.0005 and P=0.001, respectively).
Per-segment Data were provided on a per-segment basis in
seven articles, of which one evaluated both CT and scintigra-
phy, two evaluatedMRI, two evaluated US, and two evaluated
scintigraphy, respectively (Fig. 4). I2 values were 86.3 %
(95 % CI: 66.4–94.4 %) for MRI, 91.5 % (95 % CI: 79.1–
96.6 %) for US, and 0 % for scintigraphy. MRI and US data
were not pooled, as data were too heterogeneous (I2≥75 %).
Data on CT were also not pooled, as only one dataset was
available. The overall grading accuracy was 87 % (95 % CI:
77–93 %) for CT and 86 % (95 % CI: 80–91 %) for scintig-
raphy. CT and scintigraphy showed similar overall grading
accuracy (P=0.8), over-grading (P=0.2) and under-grading
(P=0.5). Accuracy for MRI and US ranged from 67 to 82 %
and 56 to 75 %, respectively.
Discussion
In this study, we have shown that MRI and CT are highly
accurate for grading Crohn’s disease activity. These findings
are important, as cross-sectional imaging plays an increasing
role in the assessment of Crohn’s disease activity, and there
has been ongoing debate regarding the modality that should be
the preferred choice [35–37]. Several studies have compared
two or more modalities in the same patient group [38–41], but
they have had relatively small sample sizes or only evaluated
the terminal ileum.
CT and MRI showed similar accuracy in grading Crohn’s
disease activity (86 % and 84% on a per-patient basis, respec-
tively), and no significant differences in accuracy were seen
between these two modalities. Data on over- and under-
grading showed similar results for CT and MRI, further
strengthening our conclusion of their comparability. Scintig-
raphy showed high accuracy of 86 % and 86 % for the studies
using per-segment data, while accuracy of 40 % was reported
in per-patient data. However, per-patient data for scintigraphy
was reported in only one study, and with a small sample size
(n=10) [34]. Furthermore, scintigraphy had the least number
of included patients (n=58) in our meta-analysis. US showed
low accuracy of 44 % in the per-patient data and 75 % and
Table 10 Comparison table with
results for imaging tests from the
3×3 data analysis and
corresponding P values
Accurate grading Over-grading Under-grading
Per-patient (13 datasets)
CT (n=2) vs MRI (n=9) 0.86 vs 0.84 (P=0.8) 0.10 vs 0.09 (P=0.8) 0.03 vs 0.06 (P=0.5)
CT (n=2) vs US (n=1) 0.86 vs 0.44 (P=0.0001) 0.10 vs 0.25 (P=0.07) 0.03 vs 0.31 (P=0.002)
CT (n=2) vs SG (n=1) 0.86 vs 0.40 (P=0.003) 0.10 vs 0.10 (P=1.0) 0.03 vs 0.50 (P=0.0005)
MRI (n=9) vs US (n=1) 0.84 vs 0.44 (P=0.001) 0.09 vs 0.25 (P=0.03) 0.06 vs 0.31 (P=0.003)
MRI (n=9) vs SG (n=1) 0.84 vs 0.40 (P=0.01) 0.09 vs 0.10 (P=0.9) 0.06 vs 0.50 (P=0.001)
US (n=1) vs SG (n=1) 0.44 vs 0.40 (P=0.8) 0.25 vs 0.10 (P=0.3) 0.31 vs 0.50 (P=0.3)
Per-segment (3 datasets) a
CT (n=1) vs SG (n=2) 0.87 vs 0.86 (P=0.8) 0.00 vs 0.04 (P=0.2) 0.13 vs 0.10 (P=0.5)
a Data onMRI and US were not pooled and included in the comparison, as the data were too heterogeneous (I2 >
75 %)
3310 Eur Radiol (2015) 25:3295–3313
56% for studies in the per-segment data. However, a relatively
small number of patients (n=86) were included. In addition,
no eligible studies evaluated luminal or intravenous contrast
medium for US. The use of intravenous contrast appears to be
a particularly promising technique, and may increase the ac-
curacy of US. However, no robust reference standard or ap-
propriate grading scale were used in these studies. We consid-
ered the possibility of performing subgroup and covariate
analyses on the differences in technique, imaging criteria, ref-
erence methods and methodological criteria, but the results of
these analyses would not be meaningful given the limited
amount of available data. We examinedMRI imaging features
in three studies with the highest accuracy values. The follow-
ing MRI features were used by at least two of these studies:
bowel wall thickness, T1 enhancement and pattern, T2 mural
signal intensity, mucosal abnormalities, presence of inflamma-
tory mass, stenosis (with pre-stenotic dilatation), lymph
nodes, abscesses, and fistulas [25, 27, 29].
The observed heterogeneity of the grading criteria for the
index and reference tests in the studies that we included, our
adjustment to construct 3×3 tables, and the differences in
available data between imaging modalities were the major
limitations of this meta-analysis. Although the grading criteria
for index and reference tests differed by study, and different
imaging features were used, the studies included showed con-
siderable overlap in the use of imaging features and grading
criteria. No generally accepted scoring systems exist for
imaging of Crohn’s disease. To construct 3×3 tables from
original 4×4 data, we merged moderate and severe disease
into one group. Our decision to merge these grades was based
on five articles [22, 23, 25, 28, 30] that had originally used 3×
3 tables; two of these studies explicitly stated that their highest
grade represented moderate and severe disease combined [25,
28]. The remaining three studies [22, 23, 30] used similar
grading criteria. Another limitation was the heterogeneity of
grading results, which we examined using I2 statistics. Fol-
lowing those results, some of the datasets could not be pooled.
In our conclusions, we took into account the greater availabil-
ity of data for MRI compared to CT, US and scintigraphy.
Furthermore, US and scintigraphy studies showed varying
results, hampering our ability to arrive at a firm conclusion.
There was only one head-to-head comparison study, which
compared CT and scintigraphy in 17 patients [18].
We selected three reference standards for this meta-analysis
[35]. Intraoperative findings served as the gold standard for
assessing Crohn’s disease. We also included endoscopy and
endoscopic biopsies as reference standards, although they are
not ideal, as they are incapable of assessing proximal ileum,
jejunum and extraluminal disease, which could have led to
incorrect estimation of disease activity. On the other hand,
surgery is performed only in select patients, whereas endos-
copy is applied across a wider spectrum. For our analysis, we
gave precedence to results from biopsies over endoscopic re-
sults, but we recognize that this was a controversial choice, as
Study Index Accurate grading Overgrading Undergrading            Accurate grading        Overgrading
test
Per-patient
Mao (14) CT 78% (61–89%) 19% (9–36%) 3% (0–19%)
Mohamed (13) CT 96% (77–99%) 0% (0–28%) 4% (1–23%)
Schil (26) MRI 99% (91–100%) 0% (0–10%) 1% (0–9%)
Gallego (25) MRI 77% (65–86%) 16% (9–28%) 7% (3–16%)
Koilakou (24) MRI 92% (74–98%) 8% (2–26%) 0% (0–28%)
Horsthuis (23): ob1 MRI 47% (24–71%) 7% (1–35%) 47% (24–71%)
Horsthuis (23): ob2 MRI 27% (10–53%) 7% (1–35%) 67% (41–85%)
Horsthuis (23): ob3 MRI 67% (41–85%) 13% (3–41%) 20% (7–47%) 
Girometti (22) MRI 91% (79–97%) 4% (1–16%) 4% (1–16%)
Horsthuis (21): ob1 MRI 55% (34–75%) 30% (14–53%) 15% (5–38%)
Horsthuis (21): ob2 MRI 75% (52–89%) 10% (3–32%) 15% (5–38%)
Florie (18): ob1 MRI 61% (43–77%) 26% (13–44%) 13% (5–30%)
Florie (18): ob2 MRI 58% (40–74%) 26% (13–44%) 16% (7–33%)
Shoenut (17) MRI 100% (58–100%) 0% (0–42%) 0% (0–42%)
Shoenut (16) MRI 74% (50–89%) 21% (8–45%) 5% (1–29%)
Drews (29) US 44% (28–61%) 25% (13–43%) 31% (18–49%)
Biancone (31) SG 40% (16–70%) 10% (1–47%) 50% (22–78%)
Per-segment
Kolkman (15) CT 87% (77–93%) 0% (0–10%) 13% (7–23%)
Schreyer (19) MRI 82% (76–87%) 2% (1–5%) 16% (11–22%)
Schreyer (20) MRI 67% (56–76%) 0% (0–9%) 33% (24–44%)
Neye (28) US 75% (67–82%) 8% (4–14%) 17% (11–24%)
Bozkurt (27) US 56% (49–63%) 33% (27–40%) 10% (7–16%)
Sciarretta (30) SG 86% (78–92%) 5% (2–11%) 9% (5–17%)
Kolkman (15) SG 86% (75–92%) 3% (1–11%) 11% (6–21%)
CT = Computed Tomography, MRI = Magnetic Resonance Imaging, US = Ultrasound, SG = Scintigraphy, ob = observer
 0     20    40    60   80   100
%
 0     20    40    60   80   100
%
 0     20    40    60   80   100
Undergrading
%
Fig. 4 Accurate grading, over- and under-grading per study on a per-patient and per-segment basis
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there is no widespread consensus on which is the better
reference standard. The number of studies included
could have been increased if VCE and/or double-
balloon enteroscopy (DBE) were also used as a refer-
ence standard. We chose not to include these studies
because interpretation of VCE and DBE has not yet
been standardized, and so this would further increase
heterogeneity in our study. A growing number of stud-
ies are using correlative statistics to examine quantita-
tive scoring systems [42]. Because we used an ordinal
outcome measure, we could not include these studies.
Nevertheless, a meta-analysis focused on this type of
data would be very useful. Finally, only patients with
suspected IBD or known Crohn’s disease were included,
possibly introducing observer bias, leading to over-
grading of disease activity.
Assessment of study quality using the QUADAS tool
showed overall moderate quality of the studies included in this
meta-analysis. The domains of reference test and patient flow
showed the highest risk of bias, while patient selection and
index test domains showed the lowest. Concern about the
applicability of patient selection and index and reference tests
was generally low.
Recently, Vermeire et al. stated that MR enterography
had become the reference standard for assessing small
and large bowel disease activity [43]. Based on our
results, we can agree with this statement. Considering
the radiation exposure from CT, it is not appropriate for
repeated examinations, even with present-day reduced
ionizing radiation exposure per examination, although
it still has an important role in the acute setting [44].
Compared to endoscopy, MRI is non-invasive and able
to investigate trans- and extramural disease, making it
possible to evaluate both the small bowel and colon in
one examination. Steps are being taken to come to a
more uniform evaluation of MRI in Crohn’s disease,
which may improve accuracy [42, 45]. Furthermore,
the versatility of MRI may be advantageous with new
sequences being studied.
In conclusion, CT and MRI can both be used to grade
disease activity in Crohn’s disease, while no conclusions can
be made on US and scintigraphy due to the limited and incon-
sistent data.
Acknowledgements The scientific guarantor of this publication is Jaap
Stoker. The authors of this manuscript declare relationships with the fol-
lowing companies: Jaap Stoker is a consultant for Robarts.
The authors of this manuscript declare no relationships with any com-
panies whose products or services may be related to the subject matter of
the article. This study has received funding through a research grant from
the European Union’s Seventh Framework Program (project number
270379). The European Union was not involved in designing and
conducting this study, did not have access to the data, and was not in-
volved in data analysis or preparation of this manuscript. One of the
authors (Shandra Bipat) has significant statistical expertise in systematic
reviews and meta-analyses. Institutional review board approval was not
required because this is a literature study.
Open Access This article is distributed under the terms of the
Creative Commons Attribution-NonCommercial 4.0 International
License (http://creativecommons.org/licenses/by-nc/4.0/), which
permits any noncommercial use, distribution, and reproduction in any
medium, provided you give appropriate credit to the original author(s)
and the source, provide a link to the Creative Commons license, and
indicate if changes were made.
References
1. Horsthuis K, Bipat S, Bennink RJ, Stoker J (2008) Inflammatory
bowel disease diagnosed with US,MR, scintigraphy, and CT: meta-
analysis of prospective studies. Radiology 247:64–79
2. Panes J, Bouzas R, ChaparroM et al (2011) Systematic review: the use
of ultrasonography, computed tomography and magnetic resonance
imaging for the diagnosis, assessment of activity and abdominal com-
plications of Crohn’s disease. Aliment Pharmacol Ther 34:125–145
3. Travis SP, Stange EF, Lemann M et al (2006) European evidence
based consensus on the diagnosis and management of Crohn’s dis-
ease: current management. Gut 55:i16–i35
4. Hommes DW, van Deventer SJ (2004) Endoscopy in inflammatory
bowel diseases. Gastroenterology 126:1561–1573
5. Fletcher JG, Fidler JL, Bruining DH, Huprich JE (2011) New con-
cepts in intestinal imaging for inflammatory bowel diseases.
Gastroenterology 140:1795–1806
6. Rimola J, Ordas I, Rodriguez S, Ricart E, Panes J (2012) Imaging
indexes of activity and severity for Crohn’s disease: current status
and future trends. Abdom Imaging 37:958–966
7. Horsthuis K, Bipat S, Stokkers PC, Stoker J (2009) Magnetic res-
onance imaging for evaluation of disease activity in Crohn’s dis-
ease: a systematic review. Eur Radiol 19:1450–1460
8. Moher D, Liberati A, Tetzlaff J, Altman DG, The PG (2009)
Preferred reporting items for systematic reviews and meta-analyses:
the PRISMA statement. PLoS Med 6, e1000097
9. Whiting PF, Rutjes AW,WestwoodME et al (2011) QUADAS-2: a
revised tool for the quality assessment of diagnostic accuracy stud-
ies. Ann Intern Med 155:529–536
10. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J (2003)
The development of QUADAS: a tool for the quality assessment of
studies of diagnostic accuracy included in systematic reviews.
BMC Med Res Methodol 3:25
11. Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of
publication bias and other sample size effects in systematic reviews of
diagnostic test accuracy was assessed. J Clin Epidemiol 58:882–893
12. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003)
Measuring inconsistency in meta-analyses. BMJ 327:557–560
13. Akaike H (1974) A new look at the statistical model identification.
IEEE Trans Autom Control 19:716–723
14. Bipat S, Zwinderman AH, Bossuyt PM, Stoker J (2007)
Multivariate random-effects approach: for meta-analysis of cancer
staging studies. Acad Radiol 14:974–984
15. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PMM (2003)
The diagnostic odds ratio: a single indicator of test performance. J
Clin Epidemiol 56:1129–1135
16. Mohamed AM, Amin SK, El-Shinnawy MA, Elfouly A, Baki AH
(2012) Role of CT enterography in assessment of Crohn’s disease
activity: correlation with histopathologic diagnosis. Egypt J Radiol
Nucl Med 43:353–359
3312 Eur Radiol (2015) 25:3295–3313
17. Mao R, Gao X, Zhu ZH et al (2013) CT enterography in evaluating
postoperative recurrence of Crohn’s disease after ileocolic resec-
tion: complementary role to endoscopy. Inflamm Bowel Dis 19:
977–982
18. Kolkman JJ, Falke TH, Roos JC et al (1996) Computed tomogra-
phy and granulocyte scintigraphy in active inflammatory bowel
disease. Comparison with endoscopy and operative findings. Dig
Dis Sci 41:641–650
19. Shoenut JP, Semelka RC, Silverman R, Yaffe CS, Micflikier AB
(1993) Magnetic resonance imaging in inflammatory bowel dis-
ease. J Clin Gastroenterol 17:73–78
20. Shoenut JP, Semelka RC, Magro CM, Silverman R, Yaffe CS,
Micflikier AB (1994) Comparison of magnetic resonance imaging
and endoscopy in distinguishing the type and severity of inflamma-
tory bowel disease. J Clin Gastroenterol 19:31–35
21. Florie J, Horsthuis K, Hommes DW et al (2005) Magnetic reso-
nance imaging compared with ileocolonoscopy in evaluating dis-
ease severity in Crohn’s disease. Clin Gastroenterol Hepatol 3:
1221–1228
22. Schreyer AG, Golder S, Scheibl K et al (2005) Dark lumen mag-
netic resonance enteroclysis in combination with MRI
colonography for whole bowel assessment in patients with
Crohn’s disease: first clinical experience. Inflamm Bowel Dis 11:
388–394
23. Schreyer AG, Rath HC, Kikinis R et al (2005) Comparison of
magnetic resonance imaging colonography with conventional co-
lonoscopy for the assessment of intestinal inflammation in patients
with inflammatory bowel disease: a feasibility study. Gut 54:
250–256
24. van Gemert-Horsthuis K, Florie J, Hommes DW et al (2006)
Feasibility of evaluating Crohn’s disease activity at 3.0 Tesla. J
Magn Reson Imaging 24:340–348
25. Girometti R, Zuiani C, Toso F et al (2008) MRI scoring
system including dynamic motility evaluation in assessing
the activity of Crohn’s disease of the terminal ileum. Acad
Radiol 15:153–164
26. Horsthuis K, de Ridder L, Smets AM et al (2010) Magnetic reso-
nance enterography for suspected inflammatory bowel disease in a
pediatric population. J Pediatr Gastroenterol Nutr 51:603–609
27. Koilakou S, Sailer J, Peloschek P et al (2010) Endoscopy and MR
enteroclysis: equivalent tools in predicting clinical recurrence in
patients with Crohn’s disease after ileocolic resection. Inflamm
Bowel Dis 16:198–203
28. Gallego JC, Echarri AI, Porta A, Ollero V (2011) Ileal Crohn’s
disease: MRI with endoscopic correlation. Eur J Radiol 80:e8–e12
29. Schill G, Iesalnieks I, Haimerl M et al (2013) Assessment of disease
behavior in patients with Crohn’s disease by MR enterography.
Inflamm Bowel Dis 19:983–990
30. Bozkurt T, Rommel T, Stabenow-Lohbauer U, Langer M,
Schmiegelow P, Lux G (1996) Sonographic bowel wall morphol-
ogy correlates with clinical and endoscopic activity in Crohn’s
disease and ulcerative colitis. Eur J Ultrasound 4:27–33
31. Neye H, Voderholzer W, Rickes S, Weber J, Wermke W, Lochs H
(2004) Evaluation of criteria for the activity of Crohn’s disease by
power Doppler sonography. Dig Dis 22:67–72
32. Drews BH, Barth TF, Hanle MM et al (2009) Comparison of
sonographically measured bowel wall vascularity, histology, and
disease activity in Crohn’s disease. Eur Radiol 19:1379–1386
33. Sciarretta G, Furno A, Mazzoni M, Basile C, Malaguti P (1993)
Technetium-99 m hexamethyl propylene amine oxime granulocyte
scintigraphy in Crohn’s disease: diagnostic and clinical relevance.
Gut 34:1364–1369
34. Biancone L, Scopinaro F, Ierardi M et al (1997) 99mTc-HMPAO
granulocyte scintigraphy in the early detection of postoperative
asymptomatic recurrence in Crohn’s disease. Dig Dis Sci 42:
1549–1556
35. Panes J, Bouhnik Y, ReinischWet al (2013) Imaging techniques for
assessment of inflammatory bowel disease: joint ECCO and
ESGAR evidence-based consensus guidelines. J Crohns Colitis 7:
556–585
36. Masselli G, Gualdi G (2013) CT and MR enterography in evaluat-
ing small bowel diseases: when to use which modality? Abdom
Imaging 38:249–259
37. Grand DJ, Harris A, Loftus EV Jr (2012) Imaging for luminal
disease and complications: CT enterography, MR enterography,
small-bowel follow-through, and ultrasound. Gastroenterol Clin N
Am 41:497–512
38. Siddiki HA, Fidler JL, Fletcher JG et al (2009) Prospective com-
parison of state-of-the-artMR enterography and CTenterography in
small-bowel Crohn’s disease. AJR Am J Roentgenol 193:113–121
39. Lee SS, Kim AY, Yang SK et al (2009) Crohn disease of the small
bowel: comparison of CT enterography, MR enterography, and
small-bowel follow-through as diagnostic techniques. Radiology
251:751–761
40. Jensen MD, Nathan T, Rafaelsen SR, Kjeldsen J (2011) Diagnostic
accuracy of capsule endoscopy for small bowel Crohn’s disease is
superior to that of MR enterography or CT enterography. Clin
Gastroenterol Hepatol 9:124–129
41. Jensen MD, Kjeldsen J, Rafaelsen SR, Nathan T (2011) Diagnostic
accuracies of MR enterography and CT enterography in symptom-
atic Crohn’s disease. Scand J Gastroenterol 46:1449–1457
42. Rimola J, Rodriguez S, Garcia-Bosch O et al (2009) Magnetic
resonance for assessment of disease activity and severity in
ileocolonic Crohn’s disease. Gut 58:1113–1120
43. Vermeire S, Ferrante M, Rutgeerts P (2013) Recent advances:
personalised use of current Crohn’s disease therapeutic options.
Gut 62:1511–1515
44. Peloquin JM, Pardi DS, Sandborn WJ et al (2008) Diagnostic ion-
izing radiation exposure in a population-based cohort of patients
with inflammatory bowel disease. Am J Gastroenterol 103:
2015–2022
45. Steward MJ, Punwani S, Proctor I et al (2012) Non-perforating
small bowel Crohn’s disease assessed by MRI enterography: deri-
vation and histopathological validation of an MR-based activity
index. Eur J Radiol 81:2080–2088
Eur Radiol (2015) 25:3295–3313 3313
